Practical consensus recommendations on management of triple-negative metastatic breast cancer

Patients with breast cancer along with metastatic estrogen and progesterone receptor (ER/PR)- and human epidermal growth factor receptor 2 (HER2)-negative tumors are referred to as having metastatic triple-negative breast cancer (mTNBC) disease. Resistance to current standard therapies such as anthr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rangarao, R., Smruti, B. K., Singh, K., Gupta, A., Batra, S., Choudhary, R. K., Sahani, S., Kabra, Vedant, Parikh, Purvish M., Aggarwal, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909290/
https://www.ncbi.nlm.nih.gov/pubmed/29721479
http://dx.doi.org/10.4103/sajc.sajc_118_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909290/
https://www.ncbi.nlm.nih.gov/pubmed/29721479
http://dx.doi.org/10.4103/sajc.sajc_118_18

Ejemplares similares